RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/15598747http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/15598747http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/15598747http://www.w3.org/2000/01/rdf-schema#comment"Neurofibromatosis 2 (NF2) is a tumor suppressor, although the molecular mechanism accounting for this effect remains unknown. Here, we show that merlin exerts its activity by inhibiting phosphatidylinositol 3-kinase (PI3-kinase), through binding to PIKE-L. Wild-type merlin, but not patient-derived mutant (L64P), binds PIKE-L and inhibits PI3-kinase activity. This suppression of PI3-kinase activity results from merlin disrupting the binding of PIKE-L to PI3-kinase. In addition, merlin suppression of PI3-kinase activity as well as schwannoma cell growth is abrogated by a single PIKE-L point mutation (P187L) that cannot bind merlin but can still activate PI3-kinase. Knocking down PIKE-L with RNA interference abolishes merlin's tumor-suppressive activity. Our data support the hypothesis that PIKE-L is an important mediator of merlin growth suppression."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.org/dc/terms/identifier"doi:10.1073/pnas.0405971102"xsd:string
http://purl.uniprot.org/citations/15598747http://purl.org/dc/terms/identifier"doi:10.1073/pnas.0405971102"xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/author"Tang X."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/author"Tang X."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/author"Ye K."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/author"Ye K."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/author"Rong R."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/author"Rong R."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/author"Gutmann D.H."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/author"Gutmann D.H."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/date"2004"xsd:gYear
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/date"2004"xsd:gYear
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/name"Proc. Natl. Acad. Sci. U.S.A."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/name"Proc. Natl. Acad. Sci. U.S.A."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/pages"18200-18205"xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/pages"18200-18205"xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/title"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/title"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L."xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/volume"101"xsd:string
http://purl.uniprot.org/citations/15598747http://purl.uniprot.org/core/volume"101"xsd:string
http://purl.uniprot.org/citations/15598747http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/15598747
http://purl.uniprot.org/citations/15598747http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/15598747